Acer Therapeutics Inc. Note Agreements
12 Contracts & Agreements
- Amendment No. 1 to Unsecured Promissory Note dated as of August 30, 2023 by and between Acer Therapeutics Inc. and Christopher Schelling (Filed With SEC on August 31, 2023)
- Unsecured Promissory Note, dated as of June 22, 2023, between Acer Therapeutics Inc. and Christopher Schelling (Filed With SEC on June 26, 2023)
- Amendment Agreement dated January 30, 2023, with respect to Secured Convertible Note Purchase Agreement between Acer Therapeutics Inc., MAM Aardvark, LLC and Marathon Healthcare... (Filed With SEC on January 31, 2023)
- Form of Secured Convertible Note issuable by Acer Therapeutics Inc. to MAM Aardvark, LLC and Marathon Healthcare Finance Fund, L.P. pursuant to the Secured Convertible Note... (Filed With SEC on March 7, 2022)
- Secured Convertible Note Purchase Agreement dated March 4, 2022, between Acer Therapeutics Inc., MAM Aardvark, LLC and Marathon Healthcare Finance Fund, L.P (Filed With SEC on March 7, 2022)
- Promissory Note, dated January 25, 2021, issued by Acer Therapeutics Inc. in favor of Relief Therapeutics Holding AG (Filed With SEC on January 25, 2021)
- OMNIBUS AMENDMENT TO ALL OUTSTANDING 12% CONVERTIBLE SECURED PROMISSORY NOTES OF OPEXA THERAPEUTICS, INC. AND ASSOCIATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 25, 2013)
- OPEXA THERAPEUTICS, INC. 12% CONVERTIBLE PROMISSORY NOTE $__________January 23, 2013 (Filed With SEC on January 23, 2013)
- OPEXA THERAPEUTICS, INC. 12% CONVERTIBLE SECURED PROMISSORY NOTE (Filed With SEC on July 26, 2012)
- NOTE PURCHASE AGREEMENT (Filed With SEC on July 26, 2012)
- EXHIBIT 4.1 FIRST AMENDMENT TO PROMISSORY NOTE AND SECURITY AGREEMENT (Filed With SEC on May 13, 2010)
- OPEXA THERAPEUTICS, INC. 10% CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 16, 2009)
